Despite the influence of treatment, MM patients with high SRRM2 expression still showed a higher proportion of plasma cell infiltration, indicating that SRRM2 expression in plasma cells may affect their proliferation and invasion. The gene discussed is SRRM2; the disease is Miyoshi myopathy.